Economy & Markets
The FDA’s $7 billion bureaucratic black box is fueling black markets
FDA review delays and broken internal tracking for reduced-risk products are fueling a multibillion-dollar illicit black market.
Read more at EXAMINER ›
Read the full story at
EXAMINER
The Gadsden Report aggregates and summarises headlines. The reporting above belongs to EXAMINER, and the link opens their page. This page exists so readers can find, share, and discuss the story here.